Literature DB >> 11406649

Truncated typeXVII collagen expression in a patient with non-herlitz junctional epidermolysis bullosa caused by a homozygous splice-site mutation.

M R van Leusden1, H H Pas, T Gedde-Dahl , A Sonnenberg, M F Jonkman.   

Abstract

SUMMARY: Type XVII collagen (180-kDa bullous pemphigoid antigen) is a structural component of hemidesmosomes. Mutations in the type XVII collagen gene (COL17A1) have been established to be the molecular basis of non-Herlitz junctional epidermolysis bullosa (JEB-nH), an inherited skin blistering disorder. Here we report for the first time truncated type XVII collagen expression, caused by homozygosity for a COL17A1 donor splice-site mutation (4261+1 g --> c), which was identified by PCR amplification on genomic DNA. By RT-PCR and sequencing of cDNA derived from mRNA from the patient's cultured keratinocytes, we provide evidence of cryptic splicing and exon skipping, most abundantly of exon 52. JEB-nH patients with COL17A1 splice-site mutations resulting in an exon skip often have no immunologically detectable type XVII collagen. However, in our patient with the generalized atrophic benign epidermolysis bullosa subtype, a small amount of type XVII collagen was detectable in the skin, and immunoblotting of cultured keratinocytes revealed that the 180-kDa protein was 10 kDa shorter. We hypothesize that the function of this truncated type XVII collagen polypeptide, which is expressed at low levels, is impaired, explaining the JEB-nH phenotype.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11406649     DOI: 10.1038/labinvest.3780297

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  2 in total

1.  Keratinocytes from patients lacking collagen XVII display a migratory phenotype.

Authors:  Kaisa Tasanen; Lucy Tunggal; Gretel Chometon; Leena Bruckner-Tuderman; Monique Aumailley
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

Review 2.  The Role of Collagen XVII in Cancer: Squamous Cell Carcinoma and Beyond.

Authors:  Virginia A Jones; Payal M Patel; Frederick T Gibson; Adriana Cordova; Kyle T Amber
Journal:  Front Oncol       Date:  2020-03-19       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.